Home approves bipartisan regulation to allow medical hashish analysis

WASHINGTON, DC – The US House of Representatives today passed non-partisan law giving authorized scientists access to federally approved dried flower and other cannabis products for research purposes.

HR 3797: Medical Marijuana Research Act, sponsored by the Co-Chair of Congressional Cannabis Caucus Count Blumenauer (D-Ore.) Was the second cannabis law reform bill that the House voted on during its session on lame ducks. Passage of the Marihuana Opportunity Reinvestment and Expungement (MORE) Act came last week on December 4th.

“The cannabis laws in this country are broken, especially those that do research. It is illegal anywhere in America to drive while under the influence of alcohol, cannabis, or other substances. But we don’t have a good impairment test because we can’t examine it … This is crazy and we have to change it. ” Blumenauer said today on the house floor.

A press release from Blumenauer’s office said the Medical Marijuana Research Act will remove research restrictions by:

  • Providing a path for researchers to study the cannabis products consumers use under government law programs.
  • Streamlining the onerous and often double licensing process for researchers who want to do marijuana research while maintaining all necessary safeguards against abuse and abuse.
  • Combating the extremely inadequate quantity and quality of medical marijuana available for such research purposes.
  • Request a report from the Secretary of the US Department of Health on the status and results of new research on marijuana benefits.

“At a time when there are four million registered medical cannabis patients, more likely to have self-medication, and 91 percent of Americans support medical cannabis, it is time to change the system. Our bill will do just that, ”added Blumenauer.

Comments are closed.